Skip to main content
. 2019 Jul-Sep;14(3):198–204. doi: 10.4103/atm.ATM_38_19

Table 4.

Demo-graphic and clinical data among studied patient according to the level of anxiety

Variables High anxiety (n=53) Low and moderate (n=64) P
Age (years) 53.37±18.71 46.37±16.25 0.034
Gender
 Male 33 (46.5) 38 (53.5) 0.44
 Female 20 (43.5) 26 (56.5)
BMI 28.69±5.53 25.68±6.25 0.041*
Educational level
 Primary-high school 25 (47.2) 36 (56.2) 0.214
 University and higher 28 (52.8) 28 (43.8)
Duration of appointment (days) 3.9±4.65 3.2±3.41 0.32
Patient category
 Inpatient 31 (39.2) 48 (60.8) 0.041*
 Outpatient 22 (57.9) 16 (42.1)
Previous procedure*
 Yes 14 (46.7) 16 (53.3) 0.51
 No 39 (44.8) 48 (55.2)
Smoking
 Yes 10 (41.7) 14 (58.3) 0.50
 No 43 (44.8) 49 (56.2)
Comorbidities
 Yes 1 or more 17 (41.5) 24 (58.5) 0.39
 No 36 (47.6) 40 (52.6)
CHF
 Yes 2 (25) 6 (75) 0.208
 No 51 (46.8) 58 (53.2)
Renal failure
 Yes 2 (25) 5 (71.4) 0.30
 No 51 (46.8) 58 (53.6)
DM
 Yes 15 (45.5) 18 (54.5) 0.89
 No 38 (45.2) 46 (54.8)
Chronic lung disease
 Yes 11 (52.4) 10 (47.6) 0.315
 No 42 (43.8) 54 (56.2)
Psychiatric disease
 Yes 3 (37.5) 5 (62.5) 0.45
 No 50 (46.3) 58 (53.7)
Sedation
 Pethidine 7 (26.9) 19 (73.1) 0.031*
 Inhaled lidocaine 11 (47.8) 12 (52.2)
 No 34 (50) 34 (50)

Percentage of the total. *Previous procedure=Previous upper or lower gastrointestinal endoscopy or previous bronchoscopy. BMI=Body mass index, CHF=Chronic heart failure, DM=Diabetes mellitus